Maculogix, Inc.
USPTO PatentsView assignee record - 15 granted patents across 3 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Maculogix ranks #18,870 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 3 technology areas.
- #18,870
- of 49,997 US assignees by volume
- 31st percentile
- by Innovation Score (29.6/100)
- 10.5
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R18870 · US Corporation #18,870 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 15 grants
- MID-PACK #18,870/49,997
- PHOTO-FINISH Lonza Cologne
- CPC-NARROW A61B · 3 areas
- INNOV-THIN 29.6/100
- CLAIMS-PAR 10.5 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2022 · 3y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Lonza Cologne GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Maculogix’s 29.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Maculogix
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Maculogix · this assignee 30
Maculogix · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Maculogix's Innovation Score is 29.6/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Maculogix?
Each dot is one of Maculogix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maculogix’s own 10.5 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Maculogix's grants concentrate
Maculogix, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 46.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (8 grants) versus a trough of 1 in 2020. By volume, Maculogix sits between Lonza Cologne GmbH and Mastronardi Produce Ltd..
Maculogix's three-year grant acceleration
Maculogix, Inc. shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Maculogix's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Lonza Cologne
Lonza Cologne GmbH
15 patents
- Lumencor
Lumencor, Inc.
15 patents
- Lumotive
Lumotive, Inc.
15 patents
- M87
M87, Inc.
15 patents
- MAP Pharmaceutica…
MAP Pharmaceuticals, Inc.
15 patents
- Mappedin
Mappedin Inc.
15 patents
- Marel Iceland EHF
Marel Iceland EHF
15 patents
- Mastronardi Produ…
Mastronardi Produce Ltd.
15 patents
- Maculogix ◀
Maculogix, Inc.
15 patents
What this shows Maculogix holds 15 patents at rank #18,865, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Maculogix
By rank, the assignees closest to #18,865 in granted patent volume.
- Lonza Cologne GmbH #18,861 · 15 patents
- Lumencor, Inc. #18,862 · 15 patents
- Lumotive, Inc. #18,863 · 15 patents
- M87, Inc. #18,864 · 15 patents
- MAP Pharmaceuticals, Inc. #18,866 · 15 patents
- Mappedin Inc. #18,867 · 15 patents
- Marel Iceland EHF #18,868 · 15 patents
- Mastronardi Produce Ltd. #18,869 · 15 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Maculogix's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Maculogix's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 31st percentile higher than 31% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 6.7% |
| 2021 | 6 | 40.0% |
| 2022 | 8 | 53.3% |
Which technologies does Maculogix, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Maculogix, Inc.'s patent record in context - here's where to go next.
- Maculogix, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 46.7% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #18,870 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Maculogix, Inc. against Lonza Cologne GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.